Reshmap Shetty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Charles Schwab Investment Management Inc. boosted its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 26.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,418,397 shares of the company’s stock after acquiring an additional 1,554,080 shares during the […]

Quattro Financial Advisors LLC lifted its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 75.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 175,000 shares of the company’s stock after purchasing an additional 75,000 shares during the quarter. Quattro Financial […]

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report) insider Reshma P. Shetty sold 37,650 shares of Ginkgo Bioworks stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $1.34, for a total transaction of $50,451.00. Following the transaction, the insider now directly owns 12,638,104 shares […]

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report) insider Reshma P. Shetty sold 37,650 shares of the firm’s stock in a transaction on Wednesday, October 4th. The shares were sold at an average price of $1.62, for a total value of $60,993.00. Following the sale, the insider now directly owns 12,788,704 shares in the […]

Ginkgo Bioworks (NYSE:DNA – Free Report) had its price target lowered by Raymond James from $5.00 to $3.50 in a report published on Thursday, Marketbeat Ratings reports. Raymond James currently has an outperform rating on the stock. A number of other equities research analysts have also recently commented on the company. The Goldman Sachs Group […]